Community Pharmacy Enhanced Dispensing Model to Improve Medication Access for Rural Patients Living with HIV

Objective: To demonstrate the utility of a community pharmacy-centric workflow for improving access to medications for high-risk, rural persons living with HIV (PLWH) in partnership with a Federally Qualified Health Center (FQHC). Setting: University-sponsored independent community pharmacy and rural FQHC providing care to PLWH. Practice Description: Patient-centered Pharmacy Program is a service designed to improve access to HIV medications for PLWH in rural Idaho. The service is delivered in partnership with a 340B-covered entity (FQHC). Practice innovation: The workflow for the service in the community pharmacy is described in detail, including time assessments and descriptions of tools and forms developed for rollout. Evaluation: Quality improvement initiatives over three years are described. Results: This service ensures medication access for rural PLWH and is sustainable for the community pharmacy. Expansion of services is feasible for the future. Conclusion: This partnership may be one that could be implemented at other rural, independent community pharmacies seeking to have outreach to rural patients with chronic medication needs. Article Type: Clinical Experience

Download Full-text

P2.155 Adherence Matters: A Patient-Centered Adherence Strategy to Achieve Maximum Health and Quality of Life Outcomes For Persons Living With HIV/AIDS in Plainfield, New Jersey

Sexually Transmitted Infections ◽

10.1136/sextrans-2013-051184.0419 ◽

2013 ◽

Vol 89 (Suppl 1) ◽

pp. A135.2-A135

Author(s):

L Kudryashova Hernandez

Keyword(s):

Quality Of Life ◽

New Jersey ◽

Life Outcomes ◽

Patient Centered ◽

Quality Of Life Outcomes ◽

Persons Living With Hiv ◽

Living With Hiv ◽

Hiv Aids

Download Full-text

Demonstration Projects for Community-Based Organization (CBOs): Prevention Case Management (PCM) for Persons Living with HIV/AIDS

PsycEXTRA Dataset ◽

10.1037/e410982005-001 ◽

2004 ◽

Author(s):

Keyword(s):

Case Management ◽

Community Based ◽

Persons Living With Hiv ◽

Community Based Organization ◽

Living With Hiv ◽

Hiv Aids

Download Full-text

New Centers for Disease Control and Prevention (CDC) Initiatives for Persons Living with HIV

PsycEXTRA Dataset ◽

10.1037/e507172006-002 ◽

2004 ◽

Author(s):

Linda Creegan ◽

Sharon Adler

Keyword(s):

Disease Control ◽

Persons Living With Hiv ◽

Control And Prevention ◽

Centers For Disease Control ◽

Living With Hiv

Download Full-text

A Lamp Shining In A Dark Place: Evangelical Ministries To Persons Living With HIV/AIDS

10.2986/tren.062-0230 ◽

2004 ◽

Author(s):

Thaddeus NOTO

Keyword(s):

Persons Living With Hiv ◽

Living With Hiv ◽

Hiv Aids

Download Full-text

Comparison of Clinical Outcomes of Persons Living With HIV by Enrollment Status in Washington, DC: Evaluation of a Large Longitudinal HIV Cohort Study (Preprint)

10.2196/preprints.16061 ◽

2019 ◽

Author(s):

Jenevieve Opoku ◽

Rupali K Doshi ◽

Amanda D Castel ◽

Ian Sorensen ◽

Michael Horberg ◽

...

Keyword(s):

Cohort Study ◽

Health Outcomes ◽

Odds Ratio ◽

Adjusted Odds Ratio ◽

Hiv Care ◽

Disease Stage ◽

People Living With Hiv ◽

Hiv Disease ◽

Persons Living With Hiv ◽

Living With Hiv

BACKGROUND HIV cohort studies have been used to assess health outcomes and inform the care and treatment of people living with HIV disease. However, there may be similarities and differences between cohort participants and the general population from which they are drawn. OBJECTIVE The objective of this analysis was to compare people living with HIV who have and have not been enrolled in the DC Cohort study and assess whether participants are a representative citywide sample of people living with HIV in the District of Columbia (DC). METHODS Data from the DC Health (DCDOH) HIV surveillance system and the DC Cohort study were matched to identify people living with HIV who were DC residents and had consented for the study by the end of 2016. Analysis was performed to identify differences between DC Cohort and noncohort participants by demographics and comorbid conditions. HIV disease stage, receipt of care, and viral suppression were evaluated. Adjusted logistic regression assessed correlates of health outcomes between the two groups. RESULTS There were 12,964 known people living with HIV in DC at the end of 2016, of which 40.1% were DC Cohort participants. Compared with nonparticipants, participants were less likely to be male (68.0% vs 74.9%, P<.001) but more likely to be black (82.3% vs 69.5%, P<.001) and have a heterosexual contact HIV transmission risk (30.3% vs 25.9%, P<.001). DC Cohort participants were also more likely to have ever been diagnosed with stage 3 HIV disease (59.6% vs 47.0%, P<.001), have a CD4 <200 cells/µL in 2017 (6.2% vs 4.6%, P<.001), be retained in any HIV care in 2017 (72.9% vs 59.4%, P<.001), and be virally suppressed in 2017. After adjusting for demographics, DC Cohort participants were significantly more likely to have received care in 2017 (adjusted odds ratio 1.8, 95% CI 1.70-2.00) and to have ever been virally suppressed (adjusted odds ratio 1.3, 95% CI 1.20-1.40). CONCLUSIONS These data have important implications when assessing the representativeness of patients enrolled in clinic-based cohorts compared with the DC-area general HIV population. As participants continue to enroll in the DC Cohort study, ongoing assessment of representativeness will be required.

Download Full-text